Asia Pacific Bioprocess Technology Market Forecast to 2028

Asia Pacific Bioprocess Technology Market Forecast to 2028

Asia Pacific Bioprocess Technology Market Forecast to 2028 – Regional Analysis By Type (Cell Culture Media Bioprocess, Chromatography Bioprocess, and Consumables & Accessories, and Others), Modality (Single Use and Multiple Use), and End User (Academic & Medical Institutions, Biopharmaceutical Companies, Research Laboratories, and Others)

Send Enquiry
Item ID: BMIRE00028868 Category: Tag:

$2,100 – $3,500

Description

The Asia Pacific bioprocess technology market is expected to grow from US$ 4,608.64 million in 2023 to US$ 11,000.75 million by 2028. It is estimated to grow at a CAGR of 19.0% from 2023 to 2028.
Emergence of Automated Real‐Time Flow Cytometry (ART‐FCM) Drive Asia Pacific Bioprocess Technology Market
Flow cytometry (FCM) and its technological possibilities have greatly advanced in the past decade as an analysis tool for single-cell properties and population distributions of different cell types in bioreactors. Along the way, a few automated Real‐Time Flow Cytometry (ART‐FCM) solutions were developed for monitoring bioreactor processes without operator interference over extended periods with a variable sampling frequency. ART‐FCM enables s long-term measurements without missing any important events in bioprocesses and uncovers temporal phenomena that are likely unknown and should be investigated in greater detail. Also, more frequent measurements can be performed at a user-defined frequency, independent of the availability of personnel. When compared with methods such as omics that are only partially available on a single-cell level, multi-parameter measurements can be easily established without the extended effort of labor and time via ART-FCM. Compared with conventional FCM studies, microfluidic devices great future potential as ART‐FCM on a chip. In this context, parallelization might become more relevant, as samples from different bioreactors or different locations inside a bioreactor setup could be analyzed simultaneously. Many aspects might also be adapted to other experimental setups where fast and reproducible real-time monitoring of fluorescent process parameters is also of interest. In conclusion, ART‐FCM will most probably advance exponentially in the upcoming years.
Asia Pacific Bioprocess Technology Market Overview
The bioprocessing capacity globally has increased at an average of 12% since the past decade, as per the BioPlan Associates Top 1000 Biofacility Index and Biomanufacturers Database report. China is well positioned as a global participant in markets with both small and large-molecule drugs, accounting for second and third position, respectively, worldwide. Also, China is home to several developers of cell and gene therapy due to China’s base for contract development and manufacturing organizations (CDMOs), accounting for ~25% of the country’s bioproduction capacity. Therefore, China has considerable biomanufacturing capabilities but strict adherence to the global GMP standards that build confidence in the biologics’ safety and effectiveness.
Asia Pacific Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Bioprocess Technology Market Segmentation
The Asia Pacific bioprocess technology market is segmented into type, modality, end user, and country.
Based on type, the Asia Pacific bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the Asia Pacific bioprocess technology market.
Based on modality, the Asia Pacific Bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the Asia Pacific bioprocess technology market.
Based on end-use, the Asia Pacific Bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the Asia Pacific bioprocess technology market.
Based on country, the Asia Pacific Bioprocess technology market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. In 2023, China segment registered a largest share in the Asia Pacific bioprocess technology market.
Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific bioprocess technology market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

, ,

Year of Publication:

At 19.0% CAGR, the Asia Pacific Bioprocess Technology Market is speculated to be worth US$ 11,000.75 million by 2028, says the research team
According to the research team’ research, the Asia Pacific bioprocess technology market was valued at US$ 4,608.64 million in 2023 and is expected to reach US$ 11,000.75 million by 2028, registering a CAGR of 19.0% from 2023 to 2028. Introducing advanced bioprocess technologies and emergence of automated real-time flow cytometry (ART‐FCM) are the critical factors attributed to the Asia Pacific bioprocess technology market expansion.
Advanced bioprocess technologies bridge R&D with production. Several players are introducing a wide range of new bioprocessing technologies in the market. On December 4, 2020, IDBS (a provider of software informatics solutions for the biotech and pharmaceutical industries) announced the launch of Polar. Polar creates a new product category called BioPharma Lifecycle Management (BPLM) to streamline drug development and production in biopharma research. Polar is designed and deployed to rapidly solve challenges associated with workflow, process quality, collaboration, and data analysis that have plagued the existing software solutions, including laboratory information management system (LIMS) and electronic laboratory notebook (ELN). As a result, there will be less human errors and an improvement in overall accuracy. It will reduce manual data processing and transcription, leading to fewer human errors and enhanced overall accuracy. It also has extensive search features that make it easier for users to locate what they are searching for, preventing the need for pointless duplication of effort. METTLER TOLEDO’s Dynochem Biologics is a purpose-built simulation software that supports upstream and downstream unit activities in bioprocessing at any scale. Bioprocess engineers and scientists use the software to choose appropriate process operating parameters and establish scales equivalency. Utilities enable quick evaluation of equipment performance with minimal data, whereas more potent models leverage the existing data streams for process characterization. Initial projects can be completed quickly with the help of responsive application expertise, rich training resources, and a model library that is already built. Peptides, mAbs, vaccinations, and viral vectors are a few examples of the many applications. Merck’s new BioContinuum Platform advances biotherapeutic drug manufacturing through improved efficiency, simplified plant operations, and greater quality and consistency. In addition, Merck’s Pellicon Single-Pass Tangential Flow Filtration aid in intensifying operations associated with the purification of therapeutic proteins. Thus, the introduction of various new-age bioprocess technologies is likely to provide lucrative opportunities for the market growth during the forecast period.
On the contrary, stringent regulatory policies hurdles the growth of Asia Pacific Bioprocess technology market.
Based on type, the Asia Pacific bioprocess, technology market is segmented into cell culture media bioprocess, chromatography bioprocess, and consumables & accessories, and others. The consumables and accessories segment held 45.1% share of Asia Pacific Bioprocess technology market in 2023, amassing US$ 2,079.35 million. It is projected to garner US$ 4,941.53 million by 2028 to expand at 18.9% CAGR during 2023-2028.
Based on modality, the Asia Pacific bioprocess technology market is bifurcated into single use and multiple use. The single use segment held 78.1% share of Asia Pacific bioprocess technology market in 2023, amassing US$ 3,601.54 million. It is projected to garner US$ 8,438.38 million by 2028 to expand at 18.6% CAGR during 2023-2028.
Based on end-use, the Asia Pacific Bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment held 53.1% share of Asia Pacific bioprocess technology market in 2023, amassing US$ 2,446.29 million. It is projected to garner US$ 5,770.44 million by 2028 to expand at 18.7% CAGR during 2023-2028.
Based on country, the Asia Pacific bioprocess technology market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 29.2% share of Asia Pacific bioprocess technology market in 2023. It was assessed at US$ 1,345.72 million in 2023 and is likely to hit US$ 3,184.72 million by 2028, exhibiting a CAGR of 18.8% during the forecast period.
Key players profiled in the Asia Pacific bioprocess technology market report are Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; STAMM Biotech; and Thermo Fisher Scientific Inc, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioprocess technology market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Bioprocess Technology Market – by Type
1.3.2 Asia Pacific Bioprocess Technology Market – by Modality
1.3.3 Asia Pacific Bioprocess Technology Market – by End User
1.3.4 Asia Pacific Bioprocess Technology Market – by Country
2. Asia Pacific Bioprocess Technology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioprocess Technology Market – Market Landscape
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. Asia Pacific Bioprocess Technology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies
5.3 Market Opportunities
5.3.1 Introducing Advanced Bioprocess Technologies
5.4 Future Trends
5.4.1 Emergence of Automated Real-Time Flow Cytometry (ART-FCM)
5.5 Impact Analysis
6. Bioprocess Technology Market – Asia Pacific Analysis
6.1 Asia Pacific Bioprocess Technology Market Revenue Forecast and Analysis
7. Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
7.3 Cell Culture Media Bioprocess
7.3.1 Overview
7.3.2 Cell Culture Media Bioprocess: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Chromatography Bioprocess
7.4.1 Overview
7.4.2 Chromatography Bioprocess: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Consumables & Accessories
7.5.1 Overview
7.5.2 Consumables & Accessories: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Bioprocess Technology Market Analysis and Forecasts to 2028 – by Modality
8.1 Overview
8.2 Asia Pacific Bioprocess Technology Market, by Modality 2022 & 2028 (%)
8.3 Single Use
8.3.1 Overview
8.3.2 Single Use: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Multiple Use
8.4.1 Overview
8.4.2 Multiple Use: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Asia Pacific Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
9.3 Academic & Medical Institutions
9.3.1 Overview
9.3.2 Academic & Medical Institutions: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Biopharmaceutical Companies
9.4.1 Overview
9.4.2 Biopharmaceutical Companies: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 Asia Pacific: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
10.1.1.1 China: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.1.4 China: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.1.5 China Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.2 Japan: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.2.4 Japan: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.2.5 Japan: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.3 India: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.3.4 India: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.3.5 India: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.4 South Korea: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 South Korea: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.4.4 South Korea: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.4.5 South Korea: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.5 Australia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Australia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.5.4 Australia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.5.5 Australia: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
11. Asia Pacific Bioprocess Technology Market – Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Merck KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sartorius AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Thermo Fisher Scientific Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Corning Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Lonza Group AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Eppendorf SE
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Repligen Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Danaher Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Research Team
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
Table 2. China Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. China Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 4. China Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. India Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. India Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 10. India Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Korea Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. South Korea Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 13. South Korea Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Australia Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Australia Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 16. Australia Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific Bioprocess Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Asia Pacific Bioprocess Technology Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Asia Pacific Bioprocess Technology Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Organic Growth Strategies in Bioprocess Technology Market
Table 21. Recent Inorganic Growth Strategies in the Asia Pacific bioprocess technology market
Table 22. Glossary of Terms

LIST OF FIGURES

Figure 1. Asia Pacific Bioprocess Technology Market Segmentation
Figure 2. Asia Pacific Bioprocess Technology Market, by Country
Figure 3. Asia Pacific Bioprocess Technology Market Overview
Figure 4. Others Segment Held Largest Share of Type Segment in Asia Pacific Bioprocess Technology Market
Figure 5. India Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia Pacific Bioprocess Technology Market Impact and Analysis
Figure 9. Asia Pacific Bioprocess Technology Market – Revenue Forecast and Analysis – 2020-2028
Figure 10. Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
Figure 11. Cell Culture Media Bioprocess: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Chromatographic Bioprocess: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Consumables & Accessories: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Asia Pacific Bioprocess Technology Market, by Modality 2022 & 2028 (%)
Figure 16. Single Use: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Use: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Asia Pacific Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
Figure 19. Academic & Medical Institutions: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Biopharmaceutical Companies: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Laboratories: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Asia Pacific Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Asia Pacific: Bioprocess Technology Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. China: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Japan: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. India: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. South Korea: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Australia: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of Asia Pacific: Bioprocess Technology Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies – Asia Pacific Bioprocess Technology Market

o Corning Inc
o Danaher Corp
o Eppendorf SE
o Lonza Group AG
o Merck KGaA
o Repligen Corp
o Sartorius AG
o Thermo Fisher Scientific Inc

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Bioprocess Technology Market Forecast to 2028”